Inter-assay variability in anti-JC virus testing for natalizumab: A Spanish cohort.

Espigares LF, Panadero AF, Sánchez MD, Chocán JLC, Ferreras ED

Open source

DOI
10.1016/j.msard.2026.107023
Published
2026 Mar
Container
Multiple sclerosis and related disorders
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107023,
  title = {Inter-assay variability in anti-JC virus testing for natalizumab: A Spanish cohort.},
  author = {Espigares LF and Panadero AF and Sánchez MD and Chocán JLC and Ferreras ED},
  year = {2026},
  journal = {Multiple sclerosis and related disorders},
  doi = {10.1016/j.msard.2026.107023},
  url = {https://doi.org/10.1016/j.msard.2026.107023}
}

RIS

TY  - JOUR
TI  - Inter-assay variability in anti-JC virus testing for natalizumab: A Spanish cohort.
AU  - Espigares LF
AU  - Panadero AF
AU  - Sánchez MD
AU  - Chocán JLC
AU  - Ferreras ED
PY  - 2026
JO  - Multiple sclerosis and related disorders
DO  - 10.1016/j.msard.2026.107023
UR  - https://doi.org/10.1016/j.msard.2026.107023
ER  - 

APA

LF, E., AF, P., MD, S., JLC, C., & ED, F. (2026). Inter-assay variability in anti-JC virus testing for natalizumab: A Spanish cohort.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2026.107023

Source records